ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 162

Depression Versus Frustration

Robert S. Katz1 and Jessica L. Polyak2, 1Rush University Medical Center, Chicago, IL, 2Rheumatology Associates S.C., Chicago, IL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: depression and fibromyalgia

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with fibromyalgia may feel depressed. But is it a clinical depression, suggesting the need for SSRI, SNRI, or other medication, or is it frustration related to the presence of the symptoms of the disease?

 

Methods: 115 fibromyalgia syndrome (FMS) patients, meeting the 2010 ACR criteria for the diagnosis, completed a questionnaire in a rheumatology office practice asking whether they were depressed and also whether they felt frustrated. The 62 FMS patients who responded yes to having depression also filled out a Patient Health Questionnaire-9 (PHQ-9) for depression. The PHQ-9 asked the following questions: little interest in doing things; feeling down/depressed; trouble with sleep; feeling tired/low energy; poor appetite; feeling bad about oneself; poor concentration; moving and speaking slowly or excessively fidgety; and thoughts of hurting oneself. Patients were asked to rate these questions based on how they felt over the last two weeks, as follows: 0 for not at all, 1 for several days, 2 for "more than half the days and 3 for nearly every day. A score of 5-9 minimal symptoms, 10-14 minor depression, 15-19 major depression, moderate; and >20 major depression, severe.

 

Results: 96 FMS patients responded yes to the question “are you frustrated?”  When asked, “Are you depressed?”, 62 FMS patients answered yes. Scores of the PHQ-9 in the 62 FMS patients feeling depressed were as follows:  12 (19.3%) that scored in the 5-9 range (“minimal symptoms”), 18 (29.2%) that scored in the 10-14 range (“minor depression”), 22 (35.4%) that scored in the 15-19 range (Major depression, moderate), and 10 (16.1%) that scored in the >20 range (Major depression, severe).

Conclusion: Of 115 patients with fibromyalgia, 62 reported depression. Using the PHQ-9 depression questionnaire 22 of these patients had a moderate major depression and 10 severe major depression. The great majority of patients with fibromyalgia express frustration but don’t meet the criteria for depression, based on the PHQ-9 questionnaire. Psychotherapy, including ventilation of the patient’s symptoms in the rheumatologist’s office, and continued in a psychologist’s or psychiatrist’s office, can be important. Separating depression, with the possibility of prescribing antidepressant medications, and frustration can be clinically and therapeutically important.


Disclosure: R. S. Katz, None; J. L. Polyak, None.

To cite this abstract in AMA style:

Katz RS, Polyak JL. Depression Versus Frustration [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/depression-versus-frustration/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/depression-versus-frustration/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology